Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$32,836,797
+$8,610,975 QoQ
Shares Held
27,377
+3.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#682
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GAMCO INVESTORS, INC. ET AL holds $86,182,010 across 9 Drug Manufacturers - General names. LLY ranks #1 (38.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
27,377 | $32,836,797 | |
| 2 | JNJ |
Johnson & Johnson
|
80,050 | $20,330,298 | |
| 3 | PFE |
Pfizer Inc
|
571,286 | $13,756,566 | |
| 4 | MRK |
Merck & Co., Inc.
|
62,672 | $8,053,352 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
82,671 | $4,763,503 | |
| 6 | ABBV |
AbbVie Inc.
|
13,603 | $3,423,058 | |
| 7 | AMGN |
Amgen Inc
|
4,618 | $1,672,270 | |
| 8 | OGN |
Organon & Co.
|
86,872 | $1,176,246 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,836,797 | 27,377 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $24,225,822 | 26,339 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $26,733,742 | 24,876 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $19,061,266 | 24,982 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $21,358,342 | 27,399 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $24,835,113 | 30,070 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $25,895,196 | 33,543 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $30,841,343 | 34,812 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $32,438,860 | 35,829 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $28,278,068 | 36,349 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $21,355,274 | 36,635 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $16,425,972 | 30,581 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $14,760,676 | 31,474 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $10,485,642 | 30,533 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $11,287,993 | 30,855 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $6,174,691 | 19,096 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,956,105 | 18,370 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,416,688 | 18,915 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $5,286,850 | 19,140 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,451,178 | 19,265 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,585,580 | 19,979 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,959,649 | 21,195 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,564,550 | 21,112 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $3,331,042 | 22,504 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $3,663,184 | 22,312 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,844,208 | 27,712 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||